Therapeutic Drug Monitoring: Research
- Five-Year Results From the Antiretroviral Research for Watoto (ARROW) Trial (March/April 2013)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- Canadian Researchers Develop Portable Device to Monitor HIV in Rural Areas (December 13, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
On TheBodyPRO.com
- Africa HIV City Care Questioned (July 21, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
On TheBodyPRO.com
- Hair Samples Can Be Used to Measure Effectiveness of Antiretrovirals, Researchers Say (March 17, 2009)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
On TheBodyPRO.com
- Using Hair to Manage HIV/AIDS and Predict Treatment Success (March 3, 2009)
From University of California-San Francisco
On TheBodyPRO.com
- Drug Level Monitoring Nearly Doubles Likelihood of Reaching Target Levels (December 17, 2007)
From aidsmap.com
- Reducing the Dose of Lopinavir/Ritonavir Is Associated With Low-Level Viremia (September 29, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy
On TheBodyPRO.com
- Wide Variability in Drug Levels Casts Doubt on the Practicality of Therapeutic Drug Monitoring (March 28, 2006)
From aidsmap.com
- New Research Explores Potential Value of Therapeutic Drug Monitoring (February 25, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Drug Monitoring and Pharmacology: More Mixes Nixed By Concentration Preoccupations (August 2004)
Highlights from a CROI 2004 post-conference workshop on drug-drug interactions.
In TAGline, from Treatment Action Group
On TheBodyPRO.com
- Dosing Agenerase + Kaletra -- Trying to Juggle, Walk and Chew Gum All at the Same Time (March/April 2004)
A study presented at CROI 2004 bolsters support for the use of therapeutic drug monitoring to customize dosing.
In Positively Aware, from Test Positive Aware Network
- To Measure or Not to Measure Drug Levels -- That Is the Question (March/April 2004)
Through the use of therapeutic drug monitoring, researchers are able to adjust patients' drug levels and reduce toxicity.
In Positively Aware, from Test Positive Aware Network
- Drug Monitoring, NRTI Activity Help Predict Lopinavir/Ritonavir Response in Experienced Patients (February 11, 2004)
In The 11th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Importance of Resistance Testing and Therapeutic Drug Monitoring for Treatment Success (September 16, 2003)
In The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, from TheBodyPRO.com
- The Inhibitory Quotient in Tipranavir/Ritonavir (July 14, 2003)
Therapeutic drug monitoring and phenotypic resistance testing are also found to be a valuable predictor of response.
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from TheBodyPRO.com
- Plasma Protease Inhibitor Levels Can Mark Nonadherence (January 23, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
On TheBodyPRO.com
- A Population Based-Analysis of Amprenavir Trough Concentrations Assessed in the Course of Therapeutic Drug Monitoring (November 21, 2002)
In The 6th International Congress on Drug Therapy in HIV Infection, from TheBodyPRO.com
- Intracellular Metabolism of AZT Leads to the Production of Significant Levels of d4T Triphosphate in HIV Infected Patients (November 19, 2002)
In The 6th International Congress on Drug Therapy in HIV Infection, from TheBodyPRO.com
- Therapeutic Drug Monitoring: Does It Make a Difference? (November 19, 2002)
In The 6th International Congress on Drug Therapy in HIV Infection, from TheBodyPRO.com
- Phenotyping and Therapeutic Drug Monitoring Complement Genotyping in Optimizing Therapy for HIV Patients (October 26, 2002)
In 40th Annual Meeting of the Infectious Diseases Society of America, from TheBodyPRO.com
- Hair Sample May Give Clues to HIV Drug Response (October 16, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
On TheBodyPRO.com
|
Advertisement
|
Email
Glossary
